SA-4503
SA-4503[edit | edit source]
SA-4503 is a synthetic compound that acts as a selective agonist for the sigma-1 receptor. It has been studied for its potential therapeutic effects in various neurological and psychiatric disorders.
Chemical Structure and Properties[edit | edit source]
SA-4503 is chemically classified as a benzylpiperazine derivative. Its IUPAC name is 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine. The compound has a molecular formula of C24H34N2O2 and a molecular weight of 382.54 g/mol.
Mechanism of Action[edit | edit source]
SA-4503 primarily exerts its effects through the sigma-1 receptor, a chaperone protein located in the endoplasmic reticulum of cells. The sigma-1 receptor is involved in modulating ion channels, neurotransmitter release, and cell survival pathways. By binding to this receptor, SA-4503 influences various cellular processes, potentially leading to neuroprotective and antidepressant effects.
Pharmacological Effects[edit | edit source]
Research has shown that SA-4503 has several pharmacological effects, including:
- Neuroprotection: SA-4503 has been demonstrated to protect neurons from apoptosis and oxidative stress in preclinical models.
- Antidepressant-like effects: In animal studies, SA-4503 has shown potential antidepressant effects, possibly through modulation of monoaminergic systems.
- Cognitive enhancement: Some studies suggest that SA-4503 may improve cognitive function, although more research is needed to confirm these effects in humans.
Clinical Research[edit | edit source]
While SA-4503 has shown promise in preclinical studies, its clinical development has been limited. Initial trials have focused on its potential use in treating Alzheimer's disease, depression, and schizophrenia. However, further studies are required to establish its efficacy and safety in humans.
Safety and Side Effects[edit | edit source]
The safety profile of SA-4503 is not fully established, as it is still under investigation. Preclinical studies have not reported significant adverse effects, but comprehensive clinical trials are necessary to determine its safety in humans.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
